Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Institute for Molecular Virology, University of Minnesota, Minneapolis, Minnesota, USA.
mBio. 2024 Apr 10;15(4):e0268623. doi: 10.1128/mbio.02686-23. Epub 2024 Mar 12.
The envelope glycoprotein (Env) trimer on the surface of human immunodeficiency virus type I (HIV-1) mediates viral entry into host CD4 T cells and is the sole target of neutralizing antibodies. Broadly neutralizing antibodies (bnAbs) that target gp120 V3-glycan of HIV-1 Env trimer are potent and block the entry of diverse HIV-1 strains. Most V3-glycan bnAbs interact, to a different extent, with a glycan attached to N332, but Asn at this position is not absolutely conserved or required for HIV-1 entry based on the prevalence of N332 in different circulating HIV-1 strains from diverse clades. Here, we studied the effects of amino acid changes at position 332 of HIV-1 Envs on HIV-1 sensitivity to antibodies, cold exposure, and soluble CD4. We further investigated how these changes affect Env function and HIV-1 infectivity . Our results suggest robust tolerability of HIV-1 Env N332 to changes, with specific changes that resulted in extended exposure of gp120 V3 loop, which is typically concealed in most primary HIV-1 isolates. Viral evolution leading to Asn at position 332 of HIV Envs is supported by the selection advantage of high levels of cell-cell fusion, transmission, and infectivity with high levels of cell surface expression and slightly higher gp120 shedding than most N332 variants. Thus, tolerance of HIV-1 Envs to different amino acids at position 332 provides increased flexibility to respond to changing conditions/environments and evade the immune system. Modeling studies of the distance between N332 glycan and specific bnAbs were in agreement with N332 glycan dependency on bnAb neutralization. Overall, our studies provide insights into the contribution of specific amino acids at position 332 to Env antigenicity, stability on ice, and conformational states.
Glycan attached to amino acid asparagine at position 332 of HIV-1 envelope glycoproteins is a main target of a subset of broadly neutralizing antibodies that block HIV-1 infection. Here, we defined the contribution of different amino acids at this position to Env antigenicity, stability on ice, and conformational states.
人类免疫缺陷病毒 I 型(HIV-1)表面的包膜糖蛋白(Env)三聚体介导病毒进入宿主 CD4 T 细胞,是中和抗体的唯一靶标。靶向 HIV-1 Env 三聚体 gp120 V3-聚糖的广泛中和抗体(bnAbs)具有强大的中和作用,并阻断多种 HIV-1 株的进入。大多数 V3-聚糖 bnAbs 不同程度地与附着在 N332 上的聚糖相互作用,但基于不同谱系的不同循环 HIV-1 株中 N332 的普遍性,该位置的天冬酰胺不是 HIV-1 进入所必需的或绝对保守的。在这里,我们研究了 HIV-1 Env 上位置 332 的氨基酸变化对 HIV-1 对抗体、冷暴露和可溶性 CD4 的敏感性的影响。我们进一步研究了这些变化如何影响 Env 功能和 HIV-1 感染性。我们的结果表明,HIV-1 Env N332 对变化具有强大的耐受性,特定的变化导致 gp120 V3 环的暴露得到扩展,而 V3 环在大多数原发性 HIV-1 分离物中通常被隐藏。导致 HIV-Env 位置 332 处天冬酰胺的病毒进化得到了高水平细胞-细胞融合、传播和感染性选择优势的支持,具有高水平的细胞表面表达和略高于大多数 N332 变体的 gp120 脱落。因此,HIV-1 Env 对位置 332 处不同氨基酸的耐受性为应对不断变化的条件/环境并逃避免疫系统提供了更大的灵活性。与 N332 聚糖对 bnAb 中和的依赖性一致,对 N332 聚糖和特定 bnAb 之间距离的建模研究。总体而言,我们的研究提供了对位置 332 处特定氨基酸对 Env 抗原性、冰上稳定性和构象状态的贡献的深入了解。
HIV-1 包膜糖蛋白上位置 332 附着的聚糖是一组广泛中和抗体的主要靶标,这些抗体可阻断 HIV-1 感染。在这里,我们确定了该位置的不同氨基酸对 Env 抗原性、冰上稳定性和构象状态的贡献。